Acousia Therapeutics GmbH: Acousia Therapeutics to present its first-in-class hearing loss treatment program with ACOU085 at the 2nd Inner Ear Therapeutics Summit in Boston
11.5.2022 10:03:28 CEST | news aktuell GmbH | Press release
(Tübingen, Germany): ACOU085 is a proprietary, first-in-class, small-molecule otoprotective drug candidate, which is currently being tested in a Phase 1b clinical trial involving age-related hearing loss (ARHL) patients. Designed to modulate a biologically validated target – the KCNQ4-encoded Kv7.4 potassium channel, which is essential for maintaining auditory function – ACOU085 is being developed for the treatment and prevention of hearing loss for a number of acquired and inherited forms of sensorineural hearing loss.
ACOU085 is characterized by a unique dual mode of action, which provides acute functional enhancement and long-term protection for the terminally differentiated sensorineural outer hair cells. “Being invited to share the translational background and progress of our ACOU085 lead program with the hearing loss drug development community at the Inner Ear Therapeutics Summit is an exciting opportunity for us,” says Dr. Jonas Dyhrfjeld-Johnsen, Chief Development Officer at Acousia Therapeutics. “I look forward to stimulating discussions with our peers in Boston.”
In addition to receiving an invitation to present “Small Molecule, KCNQ4 Agonist ACOU085 for the Treatment and Prevention of Hearing Loss”, Dr. Dyhrfjeld-Johnsen will also participate as a panelist on the panel discussion “De-risking the Early Development Process: A Robust and Comprehensive Early Development Process Is Essential to Minimize Setbacks Faced in the Clinic” and in the workshop “Mind The Gap: Calling Out the Shortfalls in the Current Inner Ear Therapeutic Development Pathway and Illuminating Solutions”.
About Acousia Therapeutics
Acousia Therapeutics GmbH is a privately-held, clinical stage biotech company based in Tübingen, Germany. The company is dedicated to the identification and development of small molecules for effective prevention and treatment of different etiologies of hearing loss. Acousia Therapeutics develops drugs for local and systemic administration.
Contacts
Tim Boelke,
M.D.
boelke@acousia.com
+49 70712988186
www.acousia.com
About news aktuell GmbH
news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
Central Council calls for prevention through education and awareness-raising3.8.2026 09:19:17 CEST | Press release
Commemorative event to mark the European Holocaust Remembrance Day for Sinti and Roma on 2 August 2026 in Auschwitz-Birkenau
CHRIST chooses fulfillmenttools and commercetools for a future-proof commerce architecture31.7.2026 12:47:56 CEST | Press release
Cologne – CHRIST Juweliere und Uhrmacher, one of Europe's most renowned jewelry retailers, is partnering with fulfillmenttools to transform the way it manages and orchestrates orders across its retail network. CHRIST is implementing the Agentic Order Management System (OMS) – as part of a broader transformation in which the retailer is building a modular, future-proof commerce architecture powered by commercetools Sphere, the autonomous commerce platform. The new system landscape spans stores and digital channels across Germany, Austria and the Netherlands. Breaking free from monolithic constraints For internationally operating retailers, the ability to respond flexibly and quickly to customer demand is a key success factor. This is especially true in the jewellery trade, which is shaped by specific requirements: high-value products, complex inventory structures, and customers who expect a first-class, seamless shopping experience at every touchpoint. CHRIST has built a strong operatio
Bikeleasing Group announces strategic investment in New Zealand’s leading bike leasing company Workride / Next strategic step in cross-continental expansion29.7.2026 14:18:02 CEST | Press release
The Bikeleasing Group announces strategic investment in Workride, New Zealand’s market leader for company bike leasing as an employee benefit. Around 2,000 New Zealand employers already use Workride’s offering. The investment extends the Bikeleasing Group’s international presence and marks its next cross-continental step in its growth trajectory.
Dr. Gunther von Hagens, Inventor of Plastination & Creator of BODY WORLDS, Has Passed Away27.7.2026 14:31:59 CEST | Press release
Heidelberg/Germany, July 27, 2026—It is with deep sadness that the family and the Institute for Plastination announce the passing of Dr. Gunther von Hagens, inventor of Plastination and creator of the BODY WORLDS exhibitions. He died on July 24, 2026, at the age of 81. Gunther von Hagens fundamentally transformed the field of anatomy. Through Plastination—the preservation technique he invented in 1977—he created an entirely new perspective of the human body for medical education, science and the general public. He made the complexity, vulnerability and beauty of the human body—previously reserved for the dissection room and anatomical textbooks –directly accessible to the wider public. Together with his wife and curator, Dr. Angelina Whalley, Gunther von Hagens created BODY WORLDS, one of the most successful exhibitions in the world. Since its debut, the exhibition has been visited by more than 58 million people. BODY WORLDS made anatomy publicly accessible, encouraged reflection on h
ZDF and SRF Launch Streamium Days 202624.7.2026 14:06:35 CEST | Press release
Mainz - A new form for media leaders Leading Today – Shaping Tomorrow As media organizations navigate fundamental shifts in streaming, distribution, artificial intelligence and platform ecosystems, ZDF and SRF are bringing together senior industry leaders for Streamium Days 2026 (September 7–8, 2026), a new international forum dedicated to the future of audience engagement and media distribution.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom